|
Biotech Business
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 419 articles |
 Page 4 of 6 
|
IGC EXPO RELEASES GENE PROFILES FOR 60 TUMOR SPECIMENS.
March 01, 2005
MORPHOSYS EXTENDS AGREEMENT WITH CENTOCOR.
February 01, 2005
RIGEL INITIATES R406 CLINICAL TRIAL FOR RHEUMATOID ARTHRITIS.
February 01, 2005
GENZYME FILES FOR EUROPEAN APPROVAL OF MYOZYME.
February 01, 2005
HUMAX-INFLAM/MDX-018 REPORTS POSITIVE SAFETY/EFFICACY DATA.
February 01, 2005
UNIVERSITY DEVELOPING STEROLS FOR CHOLESTEROL-BLOCKING.
January 01, 2005
EHEALTH INNOVATORS DRIVE HEALTH/PHARMACEUTICAL MARKETING.
January 01, 2005
MORPHOTEK GETS "TECHNOLOGY COMPANY OF THE YEAR" AWARD.
January 01, 2005
HUGO PACIFIC TO EXPLORE GENETIC DIVERSITY.
January 01, 2005
KEREOS/UNIVERSITY PROJECT FUNDED BY $7.3 MILLION GRANT.
January 01, 2005
METABOLISM/PROTEIN PROCESSING LINKED TO SCHIZOPHRENIA.
December 01, 2004
CLEARANT ASSURES MICROBIAL STERILTY/ALLOGRAFT PERFORMANCE.
December 01, 2004
SIGMA UNVEILS NEW PLASMID DNA ISOLATION METHOD.
December 01, 2004
EXELIXIS INITIATES PHASE 1 CLINICAL TRIAL FOR XL999.
December 01, 2004
HALOZYME THERAPEUTICS REITERATES ENHANZE SC TIMELINE.
November 01, 2004
PEREGRINE SUBMITS IND FOR TARVACIN ANTI-CANCER AGENT.
November 01, 2004
NOVADEL INITIATES HUMAN STUDY OF ALPRAZOLAM LINGUAL SPRAY.
November 01, 2004
ID BIOMEDICAL GETS NIH GRANT FOR INTRANASAL PLAGUE VACCINE.
November 01, 2004
NURA AWARDED NIH GRANT FOR ANXIETY RESEARCH.
November 01, 2004
VERTA AWARDED GOVERNMENT GRANT TO EVALUATE SCV-07.
October 01, 2004
BIOMARIN GETS POSITIVE DATA FROM VIBRILASE PHASE 1B TRIAL.
October 01, 2004
PHARMION SELECTS MCKESSON TO DISTRIBUTE VIDAZA.
October 01, 2004
BCX-1777 GETS ORPHAN DRUG DESIGNATION FOR 2 MORE INDICATIONS.
October 01, 2004
ASCEND FILES PATENT FOR BENIGN BREAST DISEASE DRUG.
October 01, 2004
PROVECTUS FILES FDA IND FOR TREATMENT OF MALIGNANT TUMORS.
October 01, 2004
SOMALOGIC GETS RIGHTS TO DNA MODIFICATION PATENTS.
September 01, 2004
HYBRIDON'S OLIGONUCLEOTIDES SHOW POTENT ADJUVANT ACTIVITY.
September 01, 2004
AGENSYS/GENENTECH SIGN COLLABORATION/LICENSE AGREEMENT.
September 01, 2004
ALEXION REACHES AGREEMENT WITH FDA FOR PHASE III ECULIZUMAB.
September 01, 2004
POWER3 GETS RIGHTS TO NEURODEGENERATIVE DISEASE BLOOD TEST.
September 01, 2004
GLOUCESTER PHASE 2 CLINICAL TRIAL WITH FK228 ENCOURAGING.
August 01, 2004
EXELIXIS STARTS PHASE 3 TRIAL OF XL119 FOR BILE DUCT CANCER.
August 01, 2004
BIOSANTE COMPLETES PHASE II TRIAL FOR FSD.
August 01, 2004
DYAX/GENZYME PHASE II TRIAL OF DX-88 MEETS ENDPOINT.
August 01, 2004
NEWNEURAL GETS SBIR GRANT FOR NN-818 STEM CELL TREATMENT.
July 01, 2004
453 LIFE SCIENCES AWARDED $2.4 MILLION NHGRI GRANT.
July 01, 2004
ORPHAN MEDICAL GETS POSITIVE XYREM CLINICAL RESULTS.
July 01, 2004
BAYLOR LICENSES NOROVIRUS VACCINE TECHNOLOGIES TO LICOCYTE.
July 01, 2004
MEDIMMUNE/CERUS CO-DEVELOPING THERAPEUTIC CANCER VACCINE.
June 01, 2004
DUKE/ARDAIS LAUNCH BIOREPOSITORY FOR CANCER RESEARCH.
June 01, 2004
DOWPHARMA/BRISTOL-MYERS SUIBB SIGN SOLIBILIZATION PACT.
June 01, 2004
INSPIRE LAUNCHES CLINICAL TRIAL FOR RETINAL DETACHMENT.
June 01, 2004
IDEXX GETS USDA APPROVAL OF BSE POSTMORTEM TEST.
May 01, 2004
ENZO BIOCHEM REPORTS INTERIM RESULTS FOR ALEQUEL TRIAL.
May 01, 2004
NEXMED REPORTS POSITIVE RESULTS FOR EARLY EJACULATION PRODUCT.
May 01, 2004
HYBRIDON REPORTS BENEFITS OF IMO FOR ALERGIC ASTHMA.
May 01, 2004
BIOE/USC TO DEVELOP NON-EMBRYONIC STEM CELL THERAPIES.
May 01, 2004
NOBEX REPORTS ORAL INSULIN CLINICAL TRIAL PROMISING.
April 01, 2004
FDA SELECTS DISCOVERY LAB'S SURFAXIN PROGRAM FOR CMA PILOT 2.
April 01, 2004
SCICLONE REPORTS ZADAXIN POSITIVE DATA FOR HEPATITIS PATIENTS.
April 01, 2004
UNIGEN/NCI TO ISOLATE/IDENTIFY ANTI-SOLID TUMOR COMPOUNDS.
April 01, 2004
CELLIANCE ADDS SERUM-FREE HYBRI-CYTE TO CELL CULTURE PORTFOLIO.
April 01, 2004
VERTEX LICENSES VX-944 TO AVALON FOR CANCER TREATMENT.
April 01, 2004
PROVENGE/AVASTIN IMPACT PSA DOUBLING TIME IN PROSTATE CANCER.
April 01, 2004
TRIAGE STROKE PANEL PMA ACCEPTED FOR FDA REVIEW.
April 01, 2004
BIOCRYST COMPLETES BCX-4208 PHASE I TRIAL FOR PSORIASIS.
April 01, 2004
ELIXIR LICENSES PATENT ON HUMAN LONGEVITY CHROMOSOME.
March 01, 2004
MAXIM DISCOVERS POTENTIAL THERAPEUTIC FOR SARS.
March 01, 2004
ISIS 104838 GETS PROMISING DATA FROM PHASE 2 CLINICAL TRIAL.
March 01, 2004
ALNYLAM LICENSES INTELLECTUAL PROPERTY FROM COLD SPRING HARBOR.
March 01, 2004
PARTNERSHIPS TO INTRODUCE MINI-CHROMOSOMES INTO CANOLA.
March 01, 2004
FAVRILLE COMPLETES PHASE II NON-HODGKIN'S ENROLLMENT.
February 01, 2004
VIACELL/AMGEN SIGN COLLABORATION/LICENSE PACT.
February 01, 2004
DISCOVERY LABS INITIATES PHASE 1B ASTHMA CLINICAL TRIAL.
February 01, 2004
NORTHFIELD LABS CLEARED FOR PATIENT ENROLLMENT IN PHASE III.
February 01, 2004
NOVARTIS TO DISTRIBUTE VENTERINARY SUTURE LINE IN U.S.
February 01, 2004
ANIKA SIGNS MULTI-YEAR LICENSE/SUPPLY PACT WITH ORTHO BIOTECH.
February 01, 2004
NUCRYST INITIATES PHASE 2 CLINICAL TRIAL OF ECZEMA DRUG.
January 01, 2004
PATENT ISSUED PROTECTING INTERLEUKIN-9 VACCINE TECHNOLOGY.
January 01, 2004
BIOMARIN ACCELERATES DEVELOPMENT OF PHENOPTIN FOR PKU.
January 01, 2004
LOCUS LICENSES GP41 CRYSTAL STRUCTURE FROM CORNELL RESEARCH.
December 01, 2003
GUAVA VIACOUNT FLEX ALLOWS NON-MAMMALIAN CELL COUNT/ASSESSMENT.
December 01, 2003
CERUS INITIATES PHASE IB CLINICAL TRIAL FOR ACIT.
December 01, 2003
ADAPTIVE MUTATION IS COMMON IN E.COLI.
December 01, 2003
LEVAQUIN GETS FDA APPROVAL FOR 5-DAY TREATMENT OF CAP.
December 01, 2003
|
